_version_ 1784797415964934144
author Rahmah, Laila
Abarikwu, Sunny O.
Arero, Amanuel Godana
Essouma, Mickael
Jibril, Aliyu Tijani
Fal, Andrzej
Flisiak, Robert
Makuku, Rangarirai
Marquez, Leander
Mohamed, Kawthar
Ndow, Lamin
Zarębska-Michaluk, Dorota
Rezaei, Nima
Rzymski, Piotr
author_facet Rahmah, Laila
Abarikwu, Sunny O.
Arero, Amanuel Godana
Essouma, Mickael
Jibril, Aliyu Tijani
Fal, Andrzej
Flisiak, Robert
Makuku, Rangarirai
Marquez, Leander
Mohamed, Kawthar
Ndow, Lamin
Zarębska-Michaluk, Dorota
Rezaei, Nima
Rzymski, Piotr
author_sort Rahmah, Laila
collection PubMed
description
format Online
Article
Text
id pubmed-9510311
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-95103112022-09-26 Correction: Oral antiviral treatments for COVID-19: opportunities and challenges Rahmah, Laila Abarikwu, Sunny O. Arero, Amanuel Godana Essouma, Mickael Jibril, Aliyu Tijani Fal, Andrzej Flisiak, Robert Makuku, Rangarirai Marquez, Leander Mohamed, Kawthar Ndow, Lamin Zarębska-Michaluk, Dorota Rezaei, Nima Rzymski, Piotr Pharmacol Rep Correction Springer International Publishing 2022-09-23 2022 /pmc/articles/PMC9510311/ /pubmed/36149599 http://dx.doi.org/10.1007/s43440-022-00410-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Rahmah, Laila
Abarikwu, Sunny O.
Arero, Amanuel Godana
Essouma, Mickael
Jibril, Aliyu Tijani
Fal, Andrzej
Flisiak, Robert
Makuku, Rangarirai
Marquez, Leander
Mohamed, Kawthar
Ndow, Lamin
Zarębska-Michaluk, Dorota
Rezaei, Nima
Rzymski, Piotr
Correction: Oral antiviral treatments for COVID-19: opportunities and challenges
title Correction: Oral antiviral treatments for COVID-19: opportunities and challenges
title_full Correction: Oral antiviral treatments for COVID-19: opportunities and challenges
title_fullStr Correction: Oral antiviral treatments for COVID-19: opportunities and challenges
title_full_unstemmed Correction: Oral antiviral treatments for COVID-19: opportunities and challenges
title_short Correction: Oral antiviral treatments for COVID-19: opportunities and challenges
title_sort correction: oral antiviral treatments for covid-19: opportunities and challenges
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510311/
https://www.ncbi.nlm.nih.gov/pubmed/36149599
http://dx.doi.org/10.1007/s43440-022-00410-y
work_keys_str_mv AT rahmahlaila correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT abarikwusunnyo correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT areroamanuelgodana correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT essoumamickael correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT jibrilaliyutijani correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT falandrzej correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT flisiakrobert correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT makukurangarirai correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT marquezleander correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT mohamedkawthar correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT ndowlamin correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT zarebskamichalukdorota correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT rezaeinima correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges
AT rzymskipiotr correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges